N/A
Completed N=152
Social Media Based Peer-Led Intervention for HIV Prevention
HIV · PrEP Uptake
Source: ClinicalTrials.gov NCT03213366 ↗
Enrolled (actual)
152
Serious AEs
0.0%
Results posted
Sep 2019
Primary outcomePrimary: Number of Participants Intending to Start Using PrEP Over Time — 32; 34; 33; 29 Participants — p=0.5783
Summary
The purpose of this study is to test the feasibility, acceptability, and preliminary efficacy of E-PrEP on reaching young men of color who have sex with men (YMCSM) at high-risk of HIV infection to reduce HIV acquisition. E-PrEP is a peer-designed social media-based health intervention to increase PrEP awareness, knowledge, and motivation as a tool for HIV prevention and to increase linkage to primary care.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants Intending to Start Using PrEP Over Time |
32; 34; 33; 29; 23; 27 | 0.5783 |
| PRIMARY Number of Participants Using PrEP Over Time |
13; 11; 52; 52; 17; 11 | 0.07863 |
| SECONDARY Change in PrEP Knowledge |
1.86; 1.7; 1.86; 1.83; 1.83; 1.73 | 0.8963 |
| SECONDARY PrEP Awareness |
4.14; 4.02; 4.29; 4.13; 4.52; 4.19 | 0.2433 |
| SECONDARY PrEP Stigma |
6.25; 6.78; 5.40; 6.24; 5.12; 6.0 | 0.2114 |
| SECONDARY Communication About PrEP |
8.42; 8.24; 9.14; 8.60; 8.94; 8.32 | 0.0124 sig |
| SECONDARY PrEP Barriers |
17.80; 18.73; 17.11; 18.76; 16.55; 17.84 | 0.1021 |
| SECONDARY Self-efficacy About Using PrEP |
8.26; 8.19; 8.88; 8.49; 8.75; 8.13 | 0.0818 |
Eligibility Criteria
Inclusion Criteria
- Male or Transgender individual; Ages 18-29; Have had unprotected anal sex with a male partner in the prior 12 months; Fluent in English or Spanish; Are HIV-negative or unknown status (self-report); Identify as Black and/or Latino
Exclusion Criteria
- YMCSM who do not consent/assent to study; not currently using at least one of 2 social media sites that will be used for the E-PrEP intervention (not using Facebook, or Instagram), and do not live in New York City.
Data sourced from ClinicalTrials.gov (NCT03213366). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.